50-year-old Pfizer Korea ¡°For both patients and innovation"
By Eo, Yun-Ho
19.11.04 06:10:36
°¡³ª´Ù¶ó
0
¡°Striving for patient¡¯s treatment access, but need adequate drug pricing¡±
¡°Upjohn under same leadership for a while, GSK joint venture processing still ongoing¡±
¡ãCEO Oh Dong-wook
Half a century in Korean pharmaceutical industry, Pfizer Korea seems to have mastered ¡®how to win¡¯ in the Korean market.Pfizer took its first step into the Korean market as a joint corporation with Joongang Pharmaceutical in 1962 and founded Pfizer Korea in 1969. Except for a couple of times, Pfizer Korea¡¯s sales have been the top among global pharmaceutical companies in Korea. Last year, the company had the highest sales so far of 734.4 billion won, a level no global company has ever reached.
The key to its driving force is in ¡®evolution¡¯. The company has sought after ¡®cash cow drugs¡¯ by acquiring numerous companies like Warner-Lambert Company, Wyeth, Pharmacia, and Hospira, and
Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)